A Phase 1/2 of NS-050/NCNP-03 in Boys With DMD (Meteor50)

Condition:   Duchenne Muscular Dystrophy Interventions:   Drug: NS-050/NCNP-03;   Drug: Placebo Sponsors:   NS Pharma, Inc.;   Nippon Shinyaku Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials